Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 1, 2004, Pages 59-66

  Zhang, Yahong ^a   Gray, Thackery S ^a   D'Souza, Deborah N ^a   Carrasco, Gonzalo A ^a   Damjanoska, Katerina J ^a   Dudas, Bertalan ^a   Garcia, Francisca ^a   Zainelli, Gina M ^a   Sullivan Hanley, Nicole R ^a   Battaglia, George ^a   Muma, Nancy A ^a   Van De Kar, Louis D ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIBUTYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; CORTICOTROPIN; OXYTOCIN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; AMPHETAMINE DERIVATIVE; CORTICOTROPIN RELEASING FACTOR; FLUOROBENZENE; PIPERIDINE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; IMMUNOHISTOCHEMISTRY; MALE; MENTAL DISEASE; MOOD DISORDER; NEUROSECRETORY CELL; NEUROTRANSMISSION; NONHUMAN; OXYTOCIN BLOOD LEVEL; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RECEPTOR DOWN REGULATION; SEROTONINERGIC SYSTEM; ANIMAL; ANTERIOR HYPOTHALAMUS; ANTIBODY SPECIFICITY; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MICROINJECTION; NERVE CELL; NEUROSECRETION; SPRAGUE DAWLEY RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENOCORTICOTROPIC HORMONE; AMPHETAMINES; ANIMALS; ANTIBODY SPECIFICITY; CORTICOTROPIN-RELEASING HORMONE; FLUOROBENZENES; MICROINJECTIONS; NEURONS; NEUROSECRETORY SYSTEMS; OXYTOCIN; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 4344662295     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.062224     Document Type: Article

References (65)

1. Albert PR, Zhou QY, Van Tol HH, Bunzow JR, and Civelli O (1990) Cloning, functional expression and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. J Biol Chem 265:5825-5832.
2. Alves SE, Lopez V, McEwen BS, and Weiland NG (1998) Differential colocalization of estrogen receptor beta (ERbeta) with oxytocin and vasopressin in the paraventricular and supraoptic nuclei of the female rat brain: an immunocytochemical study. Proc Natl Acad Sci USA 95:3281-3286.
3. 1A receptor: evidence for state-dependent antibody binding. Mol Brain Res 50:277-284.
4. 1c receptors in rat brain. J Pharmacol Exp Ther 255:843-857.
5. 2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav Brain Res 73:277-280.
6. 1C receptors induce oxytocin release in the male rat. Brain Res 611:330-332.
7. Berendsen HH (1995) Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans? Pharmacol Ther 66:17-37.
8. 1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects. Clin Pharmacol Ther 63:428-436.
9. Borsini F (1994) Balance between cortical 5-HT1A and 5-HT2 receptor function: hypothesis for a faster antidepressant action. Pharmacol Res 30:1-11.
10. 2 receptor function in the brain of the guinea pig. Neuropharmacology 32:249-256.
11. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mili J, Martin J, Braithwaite A, et al. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (Wash DC) 301:386-389.
12. 1A receptor antagonist WAY100635. Eur J Pharmacol 264:95-97.
13. Damjanoska KJ, Van de Kar LD, Kindel GH, Zhang Y, D'Souza DN, Garcia F, Battaglia G, and Muma NA (2003) Chronic fluoxetine differentially affects 5-HT2A receptor signaling in frontal cortex, oxytocin and corticotropin releasing factor (CRF)-containing neurons in rat paraventricular nucleus. J Pharmacol Exp Ther 306:563-571.
14. 2 receptors? Pharmacol Biochem Behav 36:901-906.
15. 2A receptors: a review of in vivo studies. Behav Brain Res 73:177-181.
16. Eison AS, Wright RN, Freeman RP, and Gylys JA (1993) 5-HT-dependent myoclonus in guinea pigs: mediation through 5-HT1A-5-HT2 receptor interaction. Brain Res Bull 30:687-689.
17. 1A receptor by phospholipid-derived signaling components. J Pharmacol Exp Ther 297:1025-1035.
18. Fields TA and Casey PJ (1995) Phosphorylation of Gz alpha by protein kinase C blocks interaction with the beta gamma complex. J Biol Chem 270:23119-23125.
19. Fritschy JM, Weinmann O, Wenzel A, and Benke D (1998) Synapse-specific localization of NMDA and GABA(A) receptor subunits revealed by antigen-retrieval immunohistochemistry. J Comp Neurol 390:194-210.
20. 1A receptor subtype increases rat plasma ACTH concentration. Eur J Pharmacol 147:431-439.
21. zα. J Biol Chem 273:26608-26013.
22. Gundlah C, Pecins-Thompson M, Schutzer WE, and Bethea CL (1999) Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. Brain Res Mol Brain Res 63:325-339.
23. Hallak H, Brass LF, and Manning DR (1994) Failure to myristoylate the alpha subunit of Gz is correlated with an inhibition of palmitoylation and membrane attachment, but has no effect on phosphorylation by protein kinase C. J Biol Chem 269:4571-4576.
24. 1A receptor sensitivity. Neuropsychopharmacology 19:354-364.
25. Hoyer D (1988) Molecular pharmacology and biology of 5-HT1C receptors. Trends Pharmacol Sci 9:89-94.
26. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, and Humphrey PP (1994) VII International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-204.
27. 1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 76:1521-1531.
28. Javed A, Kamradt MC, Van de Kar LD, and Gray TS (1999) D-fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala. Neuroscience 90:851-858.
29. 2A receptor ligand. Naunyn Schmiedebergs Arch Pharmacol 354:205-209.
30. 2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther 277:968-981.
31. 1A receptors in the rat central nervous system. J Comp Neurol 365:289-305.
32. Krebs-Thomson K and Geyer MA (1998) Evidence for a functional interaction between 5-HT1A and 5-HT2 receptors in rats. Psychopharmacology (Berl) 140:69-74.
33. 1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge. Neuropsychopharmacology 20:628-639.
34. 1A receptors in the rat brain: lack of effect by repeated injections of fluoxetine. Brain Res 769:141-151.
35. Li Q, Brownfield MS, Battaglia G, Cabrera TM, Levy AD, Rittenhouse PA, and Van de Kar LD (1993) Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (±)-1-(2,5-dimethoxy-4- iodophenyl)-2-aminopropane HCI (DOI). J Pharmacol Exp Ther 266:836-844.
36. 1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol Psychiatry 36:300-308.
37. 1A receptors. J Pharmacol Exp Ther 282:1581-1590.
38. 11-proteins. Brain Res 775:225-228.
39. Martin-Ruiz R, Puig MV, Celada P, Shapiro DA, Roth BL, Mengod G, and Artigas F (2001) Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci 21:9856-9866.
40. 1A receptor-mediated inhibition of lordosis behavior. Neuropharmacology 35:497-501.
41. 1A receptor-mediated regulation of plasma neuroendocrine hormones. J Pharmacol Exp Ther 271:1246-1252.
42. 1A receptors. J Pharmacol Exp Ther 295:853-861.
43. Morales J, Fishburn CS, Wilson PT, and Bourne HR (1998) Plasma membrane localization of G alpha z requires two signals. Mol Biol Cell 9:1-14.
44. Olivier B, Soudijn W, and van Wijngaarden I (1999) The 5-HT1A receptor and its ligands: structure and function. Prog Drug Res 52:103-165.
45. Piekut DT and Joseph SA (1986) Co-existence of CRF and vasopressin immunore-activity in parvocellular paraventricular neurons of rat hypothalamus. Peptides 7:891-898.
46. 2 receptors: low dose agonist-induced selective tolerance in the rat. Pharmacol Biochem Behav 39:407-413.
47. i proteins. J Pharmacol Exp Ther 288:98-106
48. 1A receptor. J Biol Chem 266:14747-14753.
49. 1A receptor: G protein coupling and signalling pathways. Br J Pharmacol 127:1751-1764.
50. 1A receptor and augments its desensitization by protein kinase C in CHO-K1 cells. Biochemistry 33:11264-11269.
51. 1A receptor gene. Neurosci Lett 199:191-194.
52. Shelton RC, Tollefson GD, Tohen M, Stahl S, Gannon KS, Jacobs TG, Buras WR, Bymaster FP, Zhang W, Spencer KA, et al. (2001) A novel augmentation strategy for treating resistant major depression. Am J Psychiatry 158:131-134.
53. 7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Mol Pharmacol 47:99-103.
54. Thase ME (2002) What role do atypical antipsychotic drugs have in treatment-resistant depression? J Clin Psychiatry 63:95-103.
55. 2 receptor mediated c-fos gene expression. Eur J Pharmacol Mol Pharmacol 290:263-266.
56. z. GAP and other RGS proteins by palmitoylation of G protein α subunits. Science (Wash DC) 278:1132-1135.
57. 2 receptor activation. Brain Res 957:174-182.
58. 2A receptors stimulate ACTH, corticosterone, oxytocin, renin and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells. J Neurosci 21: 3572-3579.
59. Van Wijngaarden I, Tulp MT, and Soudijn W (1990) The concept of selectivity in 5-HT receptor research. Eur J Pharmacol 188:301-312.
60. Vicentic A, Li Q, Battaglia G, and Van de Kar LD (1998) WAY-100635 inhibits 8-OH-DPAT stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion. Eur J Pharmacol 346:261-266.
61. 2 receptor subtype mRNAs in rat brain. J Comp Neurol 351:357-373.
62. 1A receptor controlling coupling to N-type calcium channels. J Physiol 538:41-51.
63. 2A receptor activation. J Neurosci 21:7919-7927.
64. Zhang Y, Damjanoska KJ, Carrasco GA, Dudas B, D'Souza DN, Tetzlaff J, Garcia F, Hanley NR, Scripathirathan K, Petersen BR, et al. (2002) Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. J Neurosci 22:9635-9642.
65. 1A binding sites. Mol Brain Res 69:186-201.